Middleton K et al. |
Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. |
2017 |
J Biomech |
pmid:28552413
|
Liu XY et al. |
Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28092862
|
Yin LL et al. |
Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. |
2017 |
Eur Rev Med Pharmacol Sci |
pmid:28121359
|
Bondar C et al. |
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. |
2017 |
Int J Mol Sci |
pmid:28098793
|
Shu R et al. |
Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. |
2017 |
PLoS ONE |
pmid:28081119
|
Ji J et al. |
Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. |
2017 |
J Toxicol Sci |
pmid:28070108
|
Sponder M et al. |
Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. |
2017 |
BMC Cardiovasc Disord |
pmid:28056805
|
Hygum K et al. |
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. |
2017 |
Eur. J. Endocrinol. |
pmid:28049653
|
Dawson S and Lawrie A |
From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. |
2017 |
Pharmacol. Ther. |
pmid:27373854
|
Yu M et al. |
Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. |
2016 Apr-Jun |
J Cancer Res Ther |
pmid:27461682
|
Gautam J et al. |
An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. |
2016 |
J. Pharm. Pharmacol. |
pmid:27265669
|
Owen S et al. |
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. |
2016 |
Int. J. Oncol. |
pmid:26781475
|
Maser RE et al. |
Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. |
2016 |
J. Diabetes Complicat. |
pmid:26775555
|
Gottesman GS et al. |
Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. |
2016 |
Am. J. Med. Genet. A |
pmid:26762549
|
Wang HL et al. |
Protein biomarkers and microbial profiles in peri-implantitis. |
2016 |
Clin Oral Implants Res |
pmid:26424287
|
Liu FQ et al. |
Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. |
2016 |
Circ. J. |
pmid:27867157
|
Kim CS et al. |
Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. |
2016 |
PLoS ONE |
pmid:27855207
|
Ye C et al. |
[Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. |
2016 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:27266195
|
Bernardi S et al. |
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. |
2016 |
Biomed Res Int |
pmid:27200369
|
Wei CC et al. |
Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. |
2016 |
Mediators Inflamm. |
pmid:27199510
|